A New At-Home Pill for Dog Lymphoma Just Got Full FDA Approval: What Las Vegas Owners Should Know
The FDA has granted full approval to Laverdia, the first oral, at-home medication built specifically for canine lymphoma. Here is what the approval actually covers and why it is not a reason to skip your vet.
Key takeaways
- Laverdia (verdinexor) received full FDA approval on June 26, 2026, becoming the first oral, at-home medication approved specifically for canine lymphoma.
- It works differently than traditional chemotherapy, blocking a protein cancer cells depend on to keep dividing, and is meant as an additional tool rather than a chemo replacement.
- The drug had been available under a conditional FDA approval since 2021; this milestone confirms its safety and effectiveness through completed studies.
- Any lymphoma diagnosis and treatment plan, including whether this drug is appropriate, still requires an in-person veterinary oncology workup, not a home decision.
Figures reflect Anivive Lifesciences' announcement and veterinary trade coverage of the FDA's June 2026 full-approval decision.
What just happened
Lymphoma is one of the more common cancers vets see in dogs, and until recently most treatment protocols leaned heavily on injectable chemotherapy given in clinic visits over several weeks. That changed this summer when the FDA's Center for Veterinary Medicine converted Laverdia, sold under the generic name verdinexor, from a conditional approval into full approval on June 26, 2026, according to Anivive Lifesciences, the company behind the drug.
Full approval is a meaningful regulatory step. Conditional approval, which the drug held since 2021 under the name Laverdia-CA1, lets a company sell a promising animal drug for a serious condition before every long-term study is finished. Full approval means the company has since completed the required effectiveness studies and the FDA has signed off that the drug does what it claims for the labeled use.
For pet owners, the headline is simple: there is now a fully approved pill that can be given at home as part of a lymphoma treatment plan, rather than requiring a clinic visit for every dose. That is a genuinely new option, not a repackaging of an older medication.
How it is different from traditional chemo
Laverdia works through a mechanism called XPO1 inhibition. In plain terms, cancer cells rely on a protein 'shuttle' to export certain tumor-suppressing proteins out of the cell nucleus so those proteins cannot do their job of stopping abnormal growth. Verdinexor blocks that shuttle, trapping the tumor-suppressing proteins inside the nucleus where they can help trigger the cancer cells to die off.
That is a different approach than classic chemotherapy drugs, which generally work by damaging rapidly dividing cells across the board. Because Laverdia targets a specific cellular pathway, the company and veterinary sources describe its safety profile as well-tolerated, though full prescribing information still lists the adverse events to watch for, and any dog on the medication should be monitored closely by their veterinarian.
Veterinary sources covering the approval have been careful to frame Laverdia as an additional tool for oncologists to consider, not a wholesale replacement for existing lymphoma protocols. The right treatment still depends on the type and stage of lymphoma, the dog's overall health, and what the family and vet decide together.
Why the at-home dosing matters for Las Vegas families
One of the bigger practical hurdles with traditional canine chemotherapy is logistics. Multi-week IV protocols mean repeat trips to a specialty or emergency clinic, which can be a real burden for working families, owners without reliable transportation, or dogs who find frequent clinic visits stressful. An oral medication that can be given at home, under a vet's guidance, can ease some of that burden.
That said, at-home dosing does not mean unsupervised. Any dog on Laverdia still needs scheduled rechecks, bloodwork, and monitoring for side effects, the same as any cancer therapy. The drug is distributed through Dechra Veterinary Products and is meant to be prescribed and managed by a veterinarian, ideally one with oncology experience or in consultation with a veterinary oncologist.
If your dog has been diagnosed with lymphoma, or you have noticed possible warning signs like unusually swollen lymph nodes under the jaw, in front of the shoulders, or behind the knees, lethargy, or reduced appetite, this news is a reason to ask your vet whether newer options like Laverdia fit your dog's specific case, not a reason to self-diagnose or delay a visit.
What this does not mean
It is worth being clear about the limits of this news. Laverdia is not a cure-all, it is not guaranteed to work the same way in every dog, and it is not something to try to obtain or dose without a licensed veterinarian's direct involvement. Lymphoma treatment decisions depend heavily on staging, subtype, and a dog's individual health picture, all of which require diagnostic workup that only an in-person exam and bloodwork can provide.
This is informational only. Nothing here is meant to diagnose your pet or substitute for a hands-on veterinary exam. If lymphoma is a concern for your dog, the right next step is scheduling a visit so a veterinarian can examine your pet directly and talk through which treatment path, including whether a newer option like this one, makes sense.
5 Things to Discuss With Your Vet If Lymphoma Comes Up
A lymphoma diagnosis is stressful, and treatment options are evolving. Here are conversation starters worth bringing to your veterinary visit.
- Ask about lymphoma subtype and staging: Treatment choices, including whether an oral option fits, depend heavily on the specific subtype and stage found on diagnostic testing.
- Ask whether a specialty referral makes sense: A board-certified veterinary oncologist can offer the most current guidance on where newer drugs fit alongside established protocols.
- Ask about monitoring requirements: Any cancer therapy, oral or injectable, typically needs scheduled bloodwork and rechecks to watch for side effects.
- Ask about cost and logistics: Compare clinic-visit chemotherapy schedules against at-home oral dosing to see what realistically fits your household.
- Know the early warning signs: Swollen lymph nodes, lethargy, and appetite changes are reasons to schedule an exam rather than wait and watch.
- Do not adjust or start any cancer medication without your vet: Dosing, drug interactions, and monitoring needs vary by dog and must be managed by a licensed veterinarian.
Frequently Asked Questions
Is Laverdia a cure for canine lymphoma?
No. It is a treatment option, and like other cancer therapies, outcomes vary by dog, lymphoma subtype, and stage. Your veterinarian is the right person to discuss realistic expectations for your pet.
Can I give my dog Laverdia without a vet prescribing it?
No. It is a prescription medication that requires veterinary diagnosis, prescribing, and ongoing monitoring. Never start any cancer medication without direct veterinary guidance.
Does this replace chemotherapy for dogs with lymphoma?
Not necessarily. Veterinary sources describe it as an additional tool oncologists can consider, not a universal replacement for existing chemotherapy protocols.
What should I do if I notice swollen lymph nodes on my dog?
Schedule a veterinary visit. Swollen lymph nodes under the jaw, in front of the shoulders, or behind the knees can have many causes, and only an exam and testing can determine what is going on.